Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,741 | -5,758 | -7,039 | -7,868 | -9,410 |
| Depreciation Amortization | 3 | 2 | 2 | 2 | 1 |
| Accounts payable and accrued liabilities | -60 | -165 | 733 | 148 | 137 |
| Other Working Capital | 213 | 503 | 877 | 625 | 234 |
| Other Operating Activity | 2,736 | 3,358 | 3,250 | 5,042 | 4,537 |
| Operating Cash Flow | $-1,850 | $-2,060 | $-2,178 | $-2,051 | $-4,502 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | N/A | N/A | -10 |
| Investing Cash Flow | $N/A | $-3 | $N/A | $N/A | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,465 | 1,369 | 2,890 | 1,655 | 4,983 |
| Debt Repayment | N/A | N/A | -2 | N/A | -46 |
| Common Stock Issued | 450 | 1,100 | N/A | 464 | N/A |
| Other Financing Activity | -25 | -351 | -491 | -20 | -402 |
| Financing Cash Flow | $1,890 | $2,119 | $2,397 | $2,099 | $4,535 |
| Exchange Rate Effect | 24 | -73 | -268 | -100 | -11 |
| Beginning Cash Position | 2 | 20 | 69 | 121 | 108 |
| End Cash Position | 67 | 2 | 20 | 69 | 121 |
| Net Cash Flow | $65 | $-18 | $-49 | $-52 | $13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,850 | -2,060 | -2,178 | -2,051 | -4,502 |
| Capital Expenditure | N/A | -3 | N/A | N/A | -10 |
| Free Cash Flow | -1,850 | -2,063 | -2,178 | -2,051 | -4,511 |